Parameter | Non-AKI group (n = 756) | AKI group (n = 40) | P | Chi-squared |
---|---|---|---|---|
Age (years), Median [25th to 75th P] | 59 [51–65] | 65 [56–68] | 0.003 | |
≥65 years, n(%) | 211 (27.9%) | 21 (52.5%) | 0.001 | 11.124 |
Weight (kg), Median [25th to 75th P] | 66.0 [60.0–75.0] | 68.5 [56.5–73.5] | 0.664 | |
Height (cm), Median [25th to 75th P] | 167.0 [160.0–172.0] | 166.0 [158.8–172.3] | 0.417 | |
Male, n(%) | 460 (60.8%) | 24 (60.0%) | 0.915 | 0.011 |
Hypertension, n(%) | 176 (23.3%) | 14 (35.0%) | 0.090 | 2.871 |
Diabetes, n(%) | 102 (13.5%) | 9 (22.5%) | 0.109 | 2.569 |
CHD, n(%) | 43 (5.7%) | 5 (12.5%) | 0.086 | |
Hepatitis B, n(%) | 307 (40.6%) | 12 (30.0%) | 0.182 | 1.780 |
ACEI/ARB, n(%) | 56 (7.4%) | 6 (15.0%) | 0.118 | |
Diuretics, n(%) | 1 (0.13%) | 0 (0%) | 1.000 | |
NSAIDs, n(%) | 24 (3.2%) | 2 (5.0%) | 0.380 | |
ASA class1–2/class 3–4 | 406/350 | 16/24 | 0.091 | 2.864 |
Major/Minor resection | 230/526 | 14/26 | 0.541 | 0.374 |
Laparoscope, n(%) | 440 | 21 | 0.477 | 0.507 |
Preinduction baseline MAP (mmHg), Median [25th to 75th P] | 96.7 [90.0–106.7] | 98.3 [93.3–105.4] | 0.351 | |
Basic laboratory characteristics | ||||
AST (IU/L), Median [25th to 75th P] | 24 [18–34] | 28 [21–47] | 0.018 | |
ALT (IU/L), Median [25th to 75th P] | 24 [16–41] | 30 [20–50] | 0.041 | |
sCr (μmol/L), Median [25th to 75th P] | 64.0 [53.0–77.7] | 55.0 [47.6–74.0] | 0.056 | |
eGFR (ml/min/1.73m2), Median [25th to 75th P] | 82.2 [67.3–100.4] | 87.9 [68.5–105.1] | 0.540 | |
BUN (μmol/L), Median [25th to 75th P] | 5.4 [6.3–4.3] | 5.4 [3.8–6.2] | 0.438 |